Pharma's reputation drops again. Could it foreshadow a return to the bottom?

Pharma's reputation continues to slide, now down to 53% of consumers who still hold a positive view. The decline began after a February high of 62% approval, down to 60% in May and then 56% in June—and now down three more percentage points, according to The Harris Poll.

The steady drip, drip of approval drops now adds up to an overall nine-point decline in six months.